null
null
OncologyStat
®
One Source, Many Resources.
®
By Elsevier
SKIN (MELANOMA) CANCER
Refine Results:
All Categories
Epidemiology and Etiology (99)
Prevention and Screening (65)
Diagnosis and Staging (132)
Treatment (265)
Supportive Oncology (18)
News
Malignancy Rates Remain Stable in Ustekinumab-Treated Patients
Elsevier Global Medical News, 2012 Jan 27, H Splete
New Certification for Complex Surgical Oncology
Elsevier Global Medical News, 2012 Jan 19, F Correa
Oncologists Embrace BRAF Testing, Coast Through Managed Care With New Melanoma Drugs
The Pink Sheet Daily, 2011 Dec 12, E Hayes
Yervoy Survival Data From First-Line Study Sealed the Deal for FDA Approval
The Pink Sheet Daily, 2011 Nov 28, S Sutter
Supplement Captures Snapshot of Melanoma Epidemiology
Elsevier Global Medical News, 2011 Nov 14, K Wachter
More News ›
Journal Scans: Research
RAS Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors
N Engl J Med, 2012 Jan 19, F Su, et al
Predictive Factors for the Development of Brain Metastasis in Advanced Unresectable Metastatic Melanoma
Am J Clin Oncol, 2011 Dec 1, AY Bedikian, et al
2-cm Versus 4-cm Surgical Excision Margins For Primary Cutaneous Melanoma Thicker Than 2 mm: A Randomised, Multicentre Trial
Lancet, 2011 Nov 5, P Gillgren, et al
Indoleamine 2,3-Dioxygenase, a New Prognostic Marker in Sentinel Lymph Nodes of Melanoma Patients
Eur J Cancer, 2011 Oct 25, R Speeckaert, et al
Sentinel Lymph Node Biopsy in Patients With Thin Primary Cutaneous Melanoma
Ann Surg, 2011 Oct 4, R Murali, et al
More Journal Scans: Research ›
Journal Scans: Review
Primary Malignant Melanoma of Head and Neck: A Comprehensive Review of Literature
Oral Oncol, 2012 Jan 20, AK Vikey, et al
Treatment Implications of the Emerging Molecular Classification System for Melanoma
Lancet Oncol, 2011 Sept 1, E Romano, et al
New Drugs in Melanoma: It's a Whole New World
Eur J Cancer, 2011 Jul 29, AMM Eggermont, et al
Potential implications of mesenchymal stem cells in cancer therapy
Cancer Lett, 2011 Jun 1, Long-Jun Dai, et al
Methods of detection of circulating melanoma cells: A comparative overview
Cancer Treat Rev, 2011 Jun 1, A Nezos, et al
More Journal Scans: Review ›
Expert Opinion
Dr. Jeffrey Kirshner: Melanoma and Lung Cancer–More Specific, Less Toxic, and More Effective Targeted Therapies
Interview by L Scott Zoeller, 2011 Nov 16, Jeffrey Kirshner, et al
Point/Counterpoint: What is the First-line Treatment of Choice for Metastatic BRAF-mutant Melanoma?
Elsevier Global Medical News, 2011 Nov 14, M Sznol, et al
Putting New Melanoma Drugs to Work in Community Practice
Elsevier Global Medical News, 2011 Jul 18, JS MacNeil
Ten Practice Changes I Will Make After Attending ASCO 2011
2011 Jun 28, Jeffrey Kirshner, et al
Dr. Paul Chapman: Exciting Times Ahead—Things Are Changing Very Quickly in Melanoma Research
OncologySTAT Editorial Team, 2011 Jun 8, Interview by L Scott Zoeller
More Expert Opinion ›
Chemotherapy Regimens
Dacarbazine, cisplatin, vinblastine, interleukin-2 (IL-2), interferon alfa-2b (Melanoma)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Temozolomide, cisplatin, vinblastine, interleukin-2 (IL-2), interferon alfa-2b (Melanoma)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Temozolomide (Melanoma)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Paclitaxel, carboplatin (Melanoma)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Paclitaxel (Melanoma)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
More Chemotherapy Regimens ›
Videos
Personalized Medicine: A Long Way to Go
EJC News Focus, 2011 Nov 1
Genotyping to Treat Advanced Melanoma
Elsevier Global Medical News, 2011 Aug 10
Dr. Alexander Eggermont: The New Era of Melanoma Research
EJC News Focus, 2011 Jul 1
Expert Gives Overview of Gamechangers at 2011 ASCO Annual Meeting
Elsevier Global Medical News, 2011 Jun 4
Ipilimumab for Metastatic Melanoma: What Clinicians Should Know About the Drug and Its Effects
Elsevier Global Medical News, 2011 Mar 16
More Videos ›
Summary of Key Points
Melanoma
Abeloff's Clinical Oncology, 4th ed. 2008
Comment
Print page
Share page
RSS feeds
Updated Key Points: Skin (Melanoma) Cancer
Summary information about skin (melanoma) cancer has been completely revised with updated information from Abeloff's Clinical Oncology, 4th ed.
Read more ›
Commentary
Ten Practice Changes I Will Make After Attending ASCO 2011
Read more ›
Categories
News
Journal Scans
Expert Opinion
Drugs and Regimens
Conferences
CME
Videos
Supportive Care
Skeletal-Related Events
Complications, GI and Oral
Hematologic Support
Infectious Complications
Neurologic Complications
Pain
Vascular Complications
Cancer Type
Bladder
Bone
Breast
Breast (ER-Positive)
CNS/Brain
Colon and Rectum
Endocrine System
Esophagus
GYN (Non-Ovary)
GYN (Ovary)
Head and Neck
Hodgkin's Lymphoma
Kidney (Renal Cell)
Leukemia
Liver and Bile Duct
Lung
Multiple Myeloma
Myelodysplastic Syndrome
Myeloproliferative Diseases
Non-Hodgkin's Lymphoma
Pancreas
Pediatric Cancers
Prostate
Rare Cancers
Skin
Soft-Tissue Sarcoma
Stomach
Testicle
SkinMelanoma/
anonymous
none
none
none
n
Advanced Search
Email Address
Password
Remember Me
Forgot your password?
Not a member?
Free registration
Elsevier
Home
Site Map
Cancer Types
About OncologySTAT
Privacy Policy
Terms of Use
Contact Us
Advertise
Copyright © 2012
Elsevier Inc.
All rights reserved.